The latest Investing Matters Podcast episode with London Stock Exchange Group's Chris Mayo has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Who would believe it, cannabis proves to be more effective for chronic pain than other treatments including opioids. All the millions of people who could be given a second chance at life, all they need is all they need is a Kanabo vape pod.
https://cannabishealthnews.co.uk/2023/03/27/a-second-chance-at-life-case-for-medicinal-cannabis-in-chronic-pain/
good news for Kanabo once they have the CE mark
https://cannabishealthnews.co.uk/2023/03/21/medical-cannabis-germany-what-you-need-to-know-new-regulations/
Granted home office licence to sell its product. this is significant, until now the only products available apart from flower had to have been through medical trials, such as Sativex. this opens things up for Kanabo, and maybe a product supply line in the short term for Treat-it.
https://www.ft.com/content/e0954eb4-af0a-45ed-8d43-267de7da7337
The MMs are collecting all the shares for when they decide to move this back up. The crazy spread is their way of manipulating the price and keeping you guessing but in sum way I feel that we are very close to a bull market even though the price may say something different.Theres not been a lack of encouraging news it just that the rewards will be delayed.
It’s really quite odd how they widen the spread …. make people pay more and take a greater slice of the pie. I actually think the volumes traded should have resulted in a higher SP…but no, the MMs just protect there book and profits! 4p will be seen again in the next month!
I would agree here. The MM's do seem to walking this one back down very slowly. We know it certainly moves with interest and volume, but without any news this could easily get back to the low 2p's. What a shame.
I thought the recent RNS would actually see this rally but instead it has dropped and the spread has closed materially. Surely this must recover lost ground……never seen such low value shares traded in my lifetime like this one! All the way this SP needs to navigate!
This could be good news for Kanabo with their new products in development as they may qualify for the governments extra financial support to small UK based life science/drug development companies as stated in the budget.
The rampers havent got around to this one yet?
Tut tut
NHS requirements for being prescribed medicinal cannabis is currently when a patient has had 2 failed prescriptions to treat pain etc and taking into account that these GPs are trained in cannabis administration and also have access to a patients medical history then i cant see there being a problem.
As they have unexpectedly announced this new service then I would expect the CE mark process must be on track to support this news.
Yes there's a possibility of another raise but I would expect that when the price has recovered a lot more
They need the CE mark
There needs to be further change to regulation in the U.K. but moving in right direction
They need to get the capital raise sorted
I did wonder how they could get GPs to actually prescribe Kanabo products. The creation of the new service specifically for cannabis products makes sense but still wonder how they get over conflict of interest issues if a GP agrees to go online to support the cannabis service and the potential patient is not suited to the product and the doctor should prescribe something else?
Currently the GP service I think is brilliant having used it myself but it’s £45 for an online appointment plus the prescribed item cost as its a private prescription. Clearly, based on revenues we know it struggles to gain traction due to the fact that too many won’t pay as they can get free from local doctors. I would pay but I think I’m a minority.
If they can somehow subsidise the call service so that those wanting the cannabis inhaler can have a GP consultation for free and the doctor just signs it off, the patient pays for the first inhaler then their local GP offers follow on under repeat and the NHS pays, I could see that being a real winner.
Much to sort out and lots of hurdles to jump
What they need is the CE mark for the vape pod now they will have direct access to patients in need of medical cannabis.
Nobody else will have what Kanabo have, high quality vape medicine for pain :)
Anyone got any level 2 data? Would be great to know if this is going to properly tick up today
Great news! The bouncing around is still outrageous! Need to settle and get back int the 4's please! Here's to some continued success
Great RNS and it plays into the market needs, these guys know how to build for future growth. Hopefully not too far into the future.
https://businesscann.com/nhs-licensed-medical-cannabis-prescriptions-grew-45-last-year-but-situation-as-intolerable-as-ever/
This should recoup losses…watch these rise again!
Online consultation and prescriptions.
Looks good to me! Hopefully, the market will agree.
:-)
I have an average of 48p just want my money bk now